Cancer Invasion and Metastasis: Positive and Negative Regulatory Elements

References

• Rosenberg S. A. Surgical Treatment of Metastotic Cancer. JB Lip-pincott, New York 1987
   Google Scholar
• Fisher B., Slack N., Katryh D., et al. Ten-year follow-up results of patients with carcinoma of the breast in a cooperative clinical trial evaluating surgical adjuvant chemotherapy. Surg Gynecol Obstet 1975; 140: 528
   PubMedGoogle Scholar
• Folkman J. Tumor angiogentsis. Adv Cancer Res 1985; 43: 175
   PubMed Web of Science ®Google Scholar
• Liotta L., Kleinerman J., Saidel G. Quantitative relationships of in-travascular tumor cells, tumor vessels and pulmonary metastasis following tumor implantations. Cancer Res 1974; 3: 497
   Google Scholar
• Laps K., Paku S., Liotta L. A. Endothelialization of embolized tumor cells during metastasis formation. Clin Exp Metast 1988; 6: 73
   PubMed Web of Science ®Google Scholar
• Schirrmacher V. Cancer metastasis: Experimental approaches, theoretical concepts, and impacts for treatment strategies. Adv Cancer Res 1985; 43: 1
   PubMed Web of Science ®Google Scholar
• Fidler I. J., Kripke M. L. Tumor cell antigenicity, host immunity and cancer metastasis. Cancer Immunol Immunother 1980; 7: 201
   Web of Science ®Google Scholar
• Nicolson G. Organ specificity of tumor metastasis: Role of preferential adhesion, invasion and growth of malignant cells at specific secondary sitcs. Cancer Metact Rev 1988; 7: 143
   PubMed Web of Science ®Google Scholar
• Hay E. Cell-matrix interaction in the embryo: Cell shape, cell surface, cell skeletons and their role in differentiation. The Role of the Extracellular Matrix in Development. Alan R. Liss, New York 1984; 1–31
   Google Scholar
• Liotta L. A. Tumor invasion and metastasis—role of the basement membrane. Am J Pathol 1984; 117: 339
   PubMed Web of Science ®Google Scholar
• Guirguis R., Margulies I., Tarabold G., et al. Cytokine-induced pseudopodial protrusion is collpleed to tumor cell migration. Nature 1987; 329: 261–263
   PubMed Web of Science ®Google Scholar
• Garbisa S., Pozzatti R., Muschel R., et al. Secretion of type IV col-lagenolytic protease and metastatic phenotype: Induction by transfection with c-Ha-ras but not C-Ha-ras plus Ad2-Ela. Cancer Res 1987; 47: 1523–1528
   PubMed Web of Science ®Google Scholar
• Collier I. E., Wilhelm S. M., Eisen A. Z., et al. H-ras oncogene transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J Biol Chem 1988; 263: 6579–6587
   PubMed Web of Science ®Google Scholar
• Greenhalgh D. A., Ysupa S. H. Malignant conversion of murine squamous papilloma cell lines by transfection with the fos oncogene. Mol Carcinogenesis 1988; 1: 134–143
   PubMed Web of Science ®Google Scholar
• Ostrowski L. E., Finch J., Krieg P., et al. Expression pattern of a gene for a secreted metalloproteinase during late stages of tumor progression. Mol Carcinogencsis 1988; 1: 13–19
   PubMed Web of Science ®Google Scholar
• Liotta L. A., Tryggvason K., Garbisa S., et al. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 1980; 284: 67–68
   PubMed Web of Science ®Google Scholar
• Muler D., Quantin B., Gesael M. C., et al. The collagenase gene family in humans consists of at least four members. Biochem J 1988; 253: 187–192
   PubMed Web of Science ®Google Scholar
• Okada Y., Nagese H., Harris E. J. A meaoproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components: Purification and characterization. J Biol Chem 1986; 261: 14245–14255
   PubMed Web of Science ®Google Scholar
• Nakajima M., Welch D., Belloni P. N., Nicolson G. L. Degradation of basement membrane Type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 1987; 47: 4869–4876
   PubMed Web of Science ®Google Scholar
• Reich R., Thompson E., Iwamoto Y., et al. Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Re 1988; 48: 3307–3312
   PubMed Web of Science ®Google Scholar
• Garbisa S., D'Errico A., Grigioni W., et al. Type IV collagenase augmentation associated with colorectal and gastric cancer progression. J Cell Physiol, (in press)
   Google Scholar
• Monteagudo C., Merino M., San-Juan J., et al. Immunohistologic distribution of type IV collagenase in normal, benign and malignant breast tissue. Am J Pathol, (in press)
   Web of Science ®Google Scholar
• Mignatti P., Robbins E., Rikin D. Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade. Cell 1986; 47: 487–498
   PubMed Web of Science ®Google Scholar
• Mignatti P., Tsuboi R., Robbins E., Rifkin D. In vitro angiogenesis on the human amniotic membrane: requirement for basic fibroblast growth factor-induced protcinases. J Cell Biol 1989; 108: 671–682
   PubMed Web of Science ®Google Scholar
• Ura H., Bonfil R. D., Reich R., et al. Expression of Type IV collagenax. and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res 1989; 49: 4615–4621
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson W. G., Krutzsch H. C., Wacher M. P., et al. The activation of human type IV collagenase proenzyme. J Biol Chem. 1989; 264: 1353–1356
   PubMed Web of Science ®Google Scholar
• Witham S. E., Murphy G., Angel P., et al. comparison of human stromelysin and collagenase by cloning and sequence analysis. Biwhem J 1986; 240: 913–916
   PubMed Web of Science ®Google Scholar
• Sanchez-Lopex R., Nicholson R., Gensel M. C., et al. Structure-function relationships in the collagenase family. J Biol Chem 1988; 263: 11892–11899
   PubMed Web of Science ®Google Scholar
• Stricklin G. P., Welgus H. G. Human skin fibroblast collagenase inhibitor. J Biol Chem. 1983; 258: 12252–122258
   PubMed Web of Science ®Google Scholar
• Carmichael D. F., Sommer A., Thomson R., et al. Primary structure and cDNA cloning of human fibroblast collagenase inhibitor. Proc Natl Acad Sci (USA) 1986; 83: 2407–2411
   PubMed Web of Science ®Google Scholar
• Thorgeirsson U. P., Liotta L. A., Kalebic T., et al. Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. J Natl Cancer Inst 1982; 69: 1049–1054
   PubMed Web of Science ®Google Scholar
• Schultz R. M., Silberman S., Persky B., et al. Inhibition by recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells. Cancer Res, 48: 5539–5545
   PubMed Web of Science ®Google Scholar
• Stetler-Stevenson W., Krutzsch H. G., Liotta L. A. Tissue inhibitor of metalloproteinase (TIMP-2). J Biol Chem 1989; 264: 17374–17378
   PubMed Web of Science ®Google Scholar
• Kokha R., Waterhouse P., Yagel S., et al. Antisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cells. Science 1989; 243: 947–950
   PubMed Web of Science ®Google Scholar
• Murray J. B., Allison K., Sudhalter J., Langer R. Purification and partial amino acid sequence of a bovine cartilagederived collagenase inhibitor. J Biol Chem 1986; 261: 4154–4159
   PubMed Web of Science ®Google Scholar
• Bevilaqua G., Sobel M. E., Liotta L., Steeg P. S. Association of low tumor cell NM23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathologic indicators of high metastatic potential. Cancer Res 1989; 49: 5185–5190
   PubMed Web of Science ®Google Scholar
• Rosengard A. M., Krutzsch H. C., Sheam A., et al. Reduced nm23/awd protein in tumor metastasis and aberrant Drawphila development. Nature 1989; 342: 177–180
   PubMed Web of Science ®Google Scholar
• Sager R. Tumor suppressor genes: the puzzle and the promise. Science 1989; 246: 1406–1412
   PubMed Web of Science ®Google Scholar